skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:005852/0408   Pages: 3
Recorded: 09/25/1991
Conveyance: CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). EFFECTIVE ON 12/17/1987
Total properties: 13
1
Patent #:
Issue Dt:
12/25/1979
Application #:
05938274
Filing Dt:
08/31/1978
Title:
THIAZINE DERIVATIVES
2
Patent #:
Issue Dt:
04/27/1982
Application #:
06088651
Filing Dt:
10/26/1979
Title:
AQUEOUS SOLUTION FOR INTRAVENOUS ADMINISTRATION
3
Patent #:
Issue Dt:
08/17/1982
Application #:
06168139
Filing Dt:
07/14/1980
Title:
PHARMACEUTICAL COMPOSITION WITH PROLONGED BRONCHOLYTIC AND TOCOLYTIC ACTIVITY
4
Patent #:
Issue Dt:
Application #:
UNAVAILABLE
Filing Dt:
Title:
5
Patent #:
Issue Dt:
Application #:
UNAVAILABLE
Filing Dt:
Title:
6
Patent #:
Issue Dt:
Application #:
UNAVAILABLE
Filing Dt:
Title:
7
Patent #:
Issue Dt:
Application #:
UNAVAILABLE
Filing Dt:
Title:
8
Patent #:
Issue Dt:
Application #:
UNAVAILABLE
Filing Dt:
Title:
9
Patent #:
Issue Dt:
Application #:
UNAVAILABLE
Filing Dt:
Title:
10
Patent #:
Issue Dt:
Application #:
UNAVAILABLE
Filing Dt:
Title:
11
Patent #:
Issue Dt:
Application #:
UNAVAILABLE
Filing Dt:
Title:
12
Patent #:
Issue Dt:
Application #:
UNAVAILABLE
Filing Dt:
Title:
13
Patent #:
Issue Dt:
Application #:
UNAVAILABLE
Filing Dt:
Title:
Assignor
1
Exec Dt:
06/19/1991
Assignee
1
Correspondence name and address
MATTHEW JACOB
WENDEROTH, LIND & PONACK
SOUTHERN BUILDING, STE. 700
805 FIFTEENTH STREET, N.W.
WASHINGTON, D.C. 20005

Search Results as of: 06/14/2024 06:02 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT